Smart nanoparticles launch genetic attack on lung cancer and cystic fibrosis

Scientists have made a key breakthrough for treating respiratory diseases by developing a new drug delivery system that transports genetic therapies directly to the lungs, opening promising possibilities for patients with conditions like lung cancer and cystic fibrosis.

The research, led by Gaurav Sahay of Oregon State University’s College of Pharmacy, was conducted in collaboration with Oregon Health & Science University and the University of Helsinki. Findings were published in a pair of…

Continue Reading


News Source: www.sciencedaily.com

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *